CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Prolung Inc  (FRES)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

Prolung Inc Income Statement Quarterly

FRES


INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
   Related Parties Amount In Cost Of Sales - - - - -
Total Revenue 0.000 0.009 0.000 0.000 0.000
   Cost of Revenue - - - - 0.010
Gross Profit 0.000 0.009 0.000 0.000 -0.010
   Selling, Administration, Marketing 0.480 0.223 0.360 0.284 0.422
   Depriciation & Amortization - - - - -
   Research and Development Expense 0.432 0.413 0.242 0.260 0.304
   Restructuring, Accretion & impairment charges - - - - -
   Other operatinig exp. /-income - - - - -
   Unusual Expense /-Income - - - - -
 Total operating costs including COS 0.912 0.636 0.602 0.544 0.736
Operating income/-loss -0.912 -0.628 -0.602 -0.544 -0.736
Other Deductions / - Income
   Interest expense 0.050 0.062 0.066 0.067 0.072
   Interest income - - - - -
   Net interest expense/-income 0.050 0.062 0.066 0.067 0.072
   Loss/ -Gain on Investment - - - - -
   Foreign Currency Transaction (Gain) Loss - - - - -
   Allowances, Health Care Trust Fund And Other - - - - -
   Unexpected (Gain) Loss - - - - -
   Other loss/ -income 0.000 0.000 -0.000 -0.000 0.000
 Total costs & expenses 0.962 0.698 0.668 0.611 0.808
Income /-loss before income taxes -0.962 -0.689 -0.668 -0.611 -0.808
   Income taxes expenses/-benefit - - - - -
Income after income taxes -0.962 -0.689 -0.668 -0.611 -0.808
   Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -0.962 -0.689 -0.668 -0.611 -0.808
   Accounting change - - - - -
   Discontinued operations - - - - -
   Extraordinary items - - - - -
Net Income/-loss -0.962 -0.689 -0.668 -0.611 -0.808
   Noncontrolling interests - - - - -
   Prefered dividends - - - - -
   Other - - - - -
Income/-loss to shareholder -0.962 -0.689 -0.668 -0.611 -0.808
   EBIT -0.912 -0.628 -0.602 -0.544 -0.736
   EBITD -0.904 -0.619 -0.594 -0.533 -0.730
   EBITDA -0.904 -0.619 -0.594 -0.533 -0.730

Per Share (GAAP Quarterly, in $) (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Basic EPS (excl. extra items) -0.04 -0.03 -0.03 -0.03 -0.04
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.04 -0.03 -0.03 -0.03 -0.04
Basic shares outstanding (Mill. of Units) 25.407 24.017 22.965 22.470 21.507
   EPS other shares - - - - -
Diluted Net EPS -0.04 -0.03 -0.03 -0.03 -0.04
Diluted average shares (Mill. of Units) 25.407 24.017 22.965 22.470 21.507
Dividend per share - - - - -


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com